Literature DB >> 1585834

An assay system utilizing devitalized bone for assessment of differentiation of osteoclast progenitors.

S Amano1, S Hanazawa, Y Kawata, K Ohta, H Kitami, S Kitano.   

Abstract

The present study provides a novel assay system to examine the differentiation of osteoclast progenitors on devitalized bone slices. We used the population of bone cells liberated enzymatically from 14-day-old mouse embryonal calvariae as a source of osteoclast progenitors. The analysis of differentiation of osteoclast progenitors into preosteoclasts and mature osteoclasts was assessed in terms of the formation of TRAP-positive cells and pits or resorption lacunae, respectively, on devitalized bone slices. Osteoclasts having bone-resorbing activity appeared when the calvarial cell population was cultured in the presence of 1 alpha,25-(OH)2D3 on devitalized bone slices. The resorbing activity increased in a 1 alpha,25-(OH)2D3 dose-related manner. However, calcitonin, a potent inhibitor of differentiation and activation of osteoclast lineage cells, reduced the area of the resorption lacunae in a dose-dependent fashion. The bone-resorbing cells on the bone slices expressed an obvious ruffled border and clear zone, structures specific to mature osteoclasts. These results suggest that osteoclast progenitors in the mouse calvarial population examined differentiated into mature osteoclasts in the presence of 1 alpha,25-(OH)2D3 on devitalized bone slices. Further, using this assay system we assessed the effect of some other osteotropic factors on the differentiation of osteoclast progenitors to mature osteoclasts. IL-1, IL-6, and PTH increased the formation of TRAP-positive cells and pits and the area of resorption lacunae in a dose-dependent fashion. However, prostaglandin E2 was unable to induce the formation of resorption lacunae, although a significant appearance of TRAP-positive cells was observed at a concentration of 200 ng/ml.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1585834     DOI: 10.1002/jbmr.5650070312

Source DB:  PubMed          Journal:  J Bone Miner Res        ISSN: 0884-0431            Impact factor:   6.741


  8 in total

1.  The relationship between the number of nuclei of an osteoclast and its resorptive capability in vitro.

Authors:  K Piper; A Boyde; S J Jones
Journal:  Anat Embryol (Berl)       Date:  1992-09

2.  A novel osteoclast precursor cell line, 4B12, recapitulates the features of primary osteoclast differentiation and function: enhanced transfection efficiency before and after differentiation.

Authors:  Shigeru Amano; Keisuke Sekine; Lynda F Bonewald; Yoshihiro Ohmori
Journal:  J Cell Physiol       Date:  2009-10       Impact factor: 6.384

3.  Porphyromonas gingivalis fimbria-stimulated bone resorption in vitro is inhibited by a tyrosine kinase inhibitor.

Authors:  S Hanazawa; Y Kawata; Y Murakami; K Naganuma; S Amano; Y Miyata; S Kitano
Journal:  Infect Immun       Date:  1995-06       Impact factor: 3.441

4.  Porphyromonas gingivalis lipopolysaccharide-stimulated bone resorption via CD14 is inhibited by broad-spectrum antibiotics.

Authors:  Y Miyata; H Takeda; S Kitano; S Hanazawa
Journal:  Infect Immun       Date:  1997-09       Impact factor: 3.441

5.  Porphyromonas gingivalis fimbria-stimulated bone resorption is inhibited through binding of the fimbriae to fibronectin.

Authors:  Y Kawata; H Iwasaka; S Kitano; S Hanazawa
Journal:  Infect Immun       Date:  1997-02       Impact factor: 3.441

6.  Malfunction of bone marrow-derived osteoclasts and the delay of bone fracture healing in diabetic mice.

Authors:  Toshiyuki Kasahara; Sinji Imai; Hideto Kojima; Miwako Katagi; Hiroshi Kimura; Lawrence Chan; Yoshitaka Matsusue
Journal:  Bone       Date:  2010-06-19       Impact factor: 4.398

7.  Porphyromonas gingivalis fimbriae stimulate bone resorption in vitro.

Authors:  Y Kawata; S Hanazawa; S Amano; Y Murakami; T Matsumoto; K Nishida; S Kitano
Journal:  Infect Immun       Date:  1994-07       Impact factor: 3.441

8.  Adenyl cyclase and interleukin 6 are downstream effectors of parathyroid hormone resulting in stimulation of bone resorption.

Authors:  E M Greenfield; S M Shaw; S A Gornik; M A Banks
Journal:  J Clin Invest       Date:  1995-09       Impact factor: 14.808

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.